Login
$PRLD
$3.35 -$0.06 (1.76%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Krishna Vaddi Also a director
Chief Executive Officer and Director
60 Since 2016
10 years
$1,348,000
Bryant D. Lim
Chief Legal Officer, Corporate Secretary, and Chief Financial Officer
55 Not stated $847,397
Peggy A. Scherle
Chief Scientific Officer
64 Since 2018
8 years
$819,729
Andrew P. Combs
Chief Chemistry Officer
60 Since 2019
7 years
Not reported
Sean P. Brusky
Chief Business Officer
49 Since 2024
2 years
Not reported
Charles Q. Morris
Chief Medical Officer
61 Since 2026
this year
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
5 of 5
stated in the proxy; 1 not stated
Average tenure
6.2 years
from year joined
Director Age On board Independent Committees Other public boards 2025 pay Source
Krishna Vaddi
60 2016
10 years
Not stated None stated None stated Paid as CEO
Paul Scherer
40 2025
1 year
Independent
Nominating and Corporate Governance Committee Compensation Committee
None stated $81,566
Katina Dorton
68 2025
1 year
Independent
Audit Committee · Chair
Fulcrum Therapeutics Inc., TScan Therapeutics Inc. Not stated
Paul A. Friedman
83 2016
10 years
Independent
Nominating and Corporate Governance Committee
Madrigal Pharmaceuticals, Inc. $102,533
David P. Bonita
50 2016
10 years
Independent
Audit Committee Compensation Committee · Chair
Acutus Medical, Inc., ImageneBio Inc., Repare Therapeutics Inc. $86,033
Martin Babler
61 2021
5 years
Independent
Audit Committee Compensation Committee
Sardona Therapeutics Inc. $78,533

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support